Company Performance Metrics
- Richard Gammack: CTO
- Bruce Rasmussen: Chief Scientific Officer
BrainStem Biometrics is on a mission to reduce risks and extend the lives of elderly critical care patients who many times leave the ICU in worse shape than when they arrived, in part to sedative mis-management. Their firm was established to address the global problem of over-sedation in critical care which costs health systems billions of dollars
each year in unnecessary costs and inefficiencies. Furthermore, sub-optimal sedation has been shown to reduce the risks of 180-day mortality for ventilated critically ill patients and has been shown to prolong the duration of ventilation by an estimated 25-40% with associated costs and inefficiencies. They also expect that the mis-management of sedation results in significant increased reliance upon post-ICU healthcare and commensurate cost burdens.
